REG - Volex PLC - Director/PDMR Shareholding

VolexAnnouncement

16/01/2025 13:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250116:nRSP6436Ta&default-theme=true

RNS Number : 6436T  Volex PLC  16 January 2025

Volex plc

("Volex" or the "Company")

Director / PDMR Shareholding

Volex plc (AIM: VLX) announces that it has been informed that John Wilson,
Non-Executive Director, purchased 10,000 ordinary shares of 25 pence in the
Company ("Ordinary Shares") on 16 January 2025, at a price of 272 pence per
share.  Following this purchase, he will hold 10,000 Ordinary Shares in
total, representing 0.01% of the ordinary issued share capital of the Company.

For further information please contact:

 Volex plc                             +44 (0)7971 156 431

 Nat Rothschild, Executive Chairman    investor.relations@volex.com (mailto:investor.relations@volex.com)

 Jon Boaden, Chief Financial Officer

 

 Peel Hunt LLP - Nominated Adviser & Joint Broker      +44 (0)20 7418 8900

 Ed Allsopp

 Dom Convey

 

 HSBC Bank plc - Joint Broker  +44 (0)20 7991 8888

 Simon Alexander

 Joe Weaving

 

 Sodali & Co  - Media Enquiries       +44 (0)20 7250 1446

 James White

 Nicholas Johnson

The information below (set out in accordance with the requirements of EU
Market Abuse Regulation) provides further detail:

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         John Wilson
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Volex PLC
 b)  LEI                                                          213800HBLQNH5FXXGE63
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary Shares of 25 pence each

     Identification code

 b)  Nature of the transaction                                    Purchase of Ordinary Shares
 c)  Price(s) and volume(s)

Price   Volume
                                                                  £2.72   10,000
 d)  Aggregated information

                                                                  See 4 c) above

     - Aggregated volume

     - Aggregated price
 e)  Date of the transaction                                      16 January 2025
 f)  Place of the transaction                                     London Stock Exchange, AIM

d)

Aggregated information

 

- Aggregated volume

- Aggregated price

 

See 4 c) above

e)

Date of the transaction

16 January 2025

f)

Place of the transaction

London Stock Exchange, AIM

 

 About Volex

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for
mission-critical applications and a global leader in power and data
connectivity solutions. Our diverse operations support international blue-chip
customers in five key sectors: Electric Vehicles, Consumer Electricals,
Medical, Complex Industrial Technology and Off-Highway. Headquartered in the
UK, we orchestrate operations across 28 advanced manufacturing facilities,
uniting 14,000 dynamic individuals from 25 different nations. Our
extraordinary products find their way to market through our localised sales
teams and authorised distributor partners, supporting Original Equipment
Manufacturers and Electronic Manufacturing Services companies across the
globe. In a world that grows more digitally complex by the day, customers
trust us to deliver power and connectivity that drives everything from
household essentials to life-saving medical equipment. Learn more at
www.volex.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHXQLFFEFLFBBB